The Evolving Treatment Paradigm for Patients with KRASG12C Mutated NSCLC and CNS Metastases

home / precision-medicine / the-evolving-treatment-paradigm-for-patients-with-krasg12c-mutated-nsclc-and-cns-metastases

Mark Socinski, MD, and Joshua Sabari, MD, discuss the treatment options for patients with KRASG12C mutated NSCLC with CNS metastases, and share advice for community oncologists treating this population.